Compare Stocks → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BLUNASDAQ:CGONYSEARCA:YOLO Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUBELLUS Health$14.74$14.62$6.38▼$14.76$1.87B0.193.08 million shs3.45 million shsCGOCalamos Global Total Return Fund$9.66-0.8%$10.09$7.90▼$10.93N/AN/A34,166 shs42,552 shsYOLOAdvisorShares Pure Cannabis ETF$3.79-0.8%$3.73$2.36▼$4.60$48.66M1.1666,283 shs28,805 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUBELLUS Health0.00%0.00%0.00%0.00%+2.08%CGOCalamos Global Total Return Fund+0.41%-4.70%-7.15%+7.39%+2.96%YOLOAdvisorShares Pure Cannabis ETF0.00%-5.21%+4.37%+11.37%+37.41%Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUBELLUS HealthN/AN/AN/AN/AN/AN/AN/AN/ACGOCalamos Global Total Return FundN/AN/AN/AN/AN/AN/AN/AN/AYOLOAdvisorShares Pure Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUBELLUS HealthN/AN/AN/AN/ACGOCalamos Global Total Return FundN/AN/AN/AN/AYOLOAdvisorShares Pure Cannabis ETF0.00N/A$5.9958.06% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUBELLUS Health$15K124,613.93N/AN/A$3.09 per share4.77CGOCalamos Global Total Return Fund$5.28MN/AN/AN/AN/AN/AYOLOAdvisorShares Pure Cannabis ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUBELLUS Health-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/ACGOCalamos Global Total Return FundN/AN/A0.00∞N/AN/AN/AN/AN/AYOLOAdvisorShares Pure Cannabis ETFN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUBELLUS HealthN/AN/AN/AN/AN/ACGOCalamos Global Total Return Fund$0.969.94%-7.17%N/AN/AYOLOAdvisorShares Pure Cannabis ETF$0.020.53%N/AN/AN/ALatest YOLO, FFWD, CGO, KRM, and BLU DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/1/2024CGOCalamos Global Total Return FundMonthly$0.089.36%4/11/20244/12/20244/19/20243/1/2024CGOCalamos Global Total Return FundMonthly$0.089.61%3/13/20243/14/20243/21/20242/1/2024CGOCalamos Global Total Return FundMonthly$0.0810.27%2/9/20242/12/20242/20/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUBELLUS HealthN/A33.4233.42CGOCalamos Global Total Return FundN/AN/AN/AYOLOAdvisorShares Pure Cannabis ETFN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUBELLUS Health90.37%CGOCalamos Global Total Return FundN/AYOLOAdvisorShares Pure Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipBLUBELLUS Health24.17%CGOCalamos Global Total Return FundN/AYOLOAdvisorShares Pure Cannabis ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBLUBELLUS Health74126.81 million96.16 millionNot OptionableCGOCalamos Global Total Return FundN/AN/AN/ANot OptionableYOLOAdvisorShares Pure Cannabis ETFN/A12.84 millionN/ANot OptionableYOLO, FFWD, CGO, KRM, and BLU HeadlinesSourceHeadlineWhite House says marijuana rescheduling review is now with DOJmsn.com - April 18 at 1:20 PMETF Themes That Dominated in Q1 2023etftrends.com - March 25 at 5:41 PMIs Rescheduling a Certainty for Cannabis? ETFs That Surgezacks.com - March 22 at 9:36 AMCannabis Stocks Gain Following Rumors of Imminent Reschedulingmarketwatch.com - March 17 at 7:52 PMYOLO Apr 2024 4.000 callfinance.yahoo.com - March 16 at 11:18 PMMSOS Mar 2024 6.500 callfinance.yahoo.com - March 15 at 9:03 PMYOLO Apr 2024 3.000 putfinance.yahoo.com - March 15 at 9:03 PMCannabis Stocks Hit The Roof As Hedge Funder Says Federal Descheduling Imminentbenzinga.com - March 15 at 10:54 AMAdvisorShares Pure US Cannabis ETF (MSOS)investing.com - March 1 at 3:01 PMMSOS Mar 2024 4.500 putfinance.yahoo.com - February 25 at 12:00 PMMSOS Sep 2024 7.000 putfinance.yahoo.com - February 22 at 8:48 PMAdvisorShares Pure Cannabis ETF (YOLO)au.finance.yahoo.com - February 19 at 6:19 AMThis Cannabis ETF Is Already Up Nearly 40% in 2024: Is Now the Time to Load Up on Pot Stocks?msn.com - February 17 at 10:34 AMThese 'High' Flying Stocks Smoke The Magnificent Seveninvestors.com - February 15 at 8:00 AMOOKA's Healthier Approach to Cannabis Consumptionmsn.com - February 7 at 3:29 AMCannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industrybenzinga.com - January 16 at 1:47 PMCannabis regulation: Where reform could come from in 2024finance.yahoo.com - January 9 at 12:34 PMAdvisorShares Pure Cannabis ETF declares quarterly distribution of $0.0078msn.com - December 28 at 7:56 AMAdvisorShares Pure Cannabis ETF declares quarterly distribution of $0.0100msn.com - December 22 at 6:16 PMCanopy Growth: What next for the vulnerable CGC stock?invezz.com - December 20 at 1:09 PM2024 Could Be the Year of the Cannabis Stock Comeback. Here's How to Invest.msn.com - December 14 at 7:53 AMCannabis 'legalization is inevitable,' says policy analyst—what to know before you investmsn.com - November 28 at 11:27 PMInvestor Alert: Cannabis Stocks Surge On Ohio Legalizationmsn.com - November 8 at 6:40 PMOhio Voters Just Provided The US Cannabis Industry With a Major Tipping Pointmsn.com - November 8 at 1:40 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsBELLUS HealthNASDAQ:BLUBELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.Calamos Global Total Return FundNASDAQ:CGOCalamos Global Total Return Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. It is managed by Calamos Advisors LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating across diversified sectors. The fund primarily invests in equities, convertible bonds, and high yield corporate bonds. It employs both fundamental and quantitative analysis to create its portfolio. The fund benchmarks the performance of its portfolio against MSCI World Index. Calamos Global Total Return Fund was formed on March 30, 2004 and is domiciled in the United States.AdvisorShares Pure Cannabis ETFNYSEARCA:YOLOThe AdvisorShares Pure Cannabis ETF (YOLO) is an exchange-traded fund that is based on the Prime Alternative Harvest index. The fund is an actively-managed ETF that seeks long-term capital appreciation by investing in both domestic and foreign cannabis equities, as well as total return swaps of similar securities. YOLO was launched on Apr 17, 2019 and is managed by AdvisorShares. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.